Zobrazeno 1 - 10
of 126
pro vyhledávání: '"Ann C. Mladek"'
Autor:
Elizabeth C. Randall, Kristina B. Emdal, Janice K. Laramy, Minjee Kim, Alison Roos, David Calligaris, Michael S. Regan, Shiv K. Gupta, Ann C. Mladek, Brett L. Carlson, Aaron J. Johnson, Fa-Ke Lu, X. Sunney Xie, Brian A. Joughin, Raven J. Reddy, Sen Peng, Walid M. Abdelmoula, Pamela R. Jackson, Aarti Kolluri, Katherine A. Kellersberger, Jeffrey N. Agar, Douglas A. Lauffenburger, Kristin R. Swanson, Nhan L. Tran, William F. Elmquist, Forest M. White, Jann N. Sarkaria, Nathalie Y. R. Agar
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-13 (2018)
Despite major drug discovery efforts, the therapeutic options for glioblastoma (GBM) remain inadequate. Here they analyze patient-derived xenograft model of GBM to quantitatively map distribution and cellular response to the EGFR inhibitor erlotinib,
Externí odkaz:
https://doaj.org/article/17219987055045cbbd74e20d4356a523
Autor:
Shiv K. Gupta, Emily J. Smith, Ann C. Mladek, Shulan Tian, Paul A. Decker, Sani H. Kizilbash, Gaspar J. Kitange, Jann N. Sarkaria
Publikováno v:
Frontiers in Oncology, Vol 8 (2019)
Prognosis of patients with glioblastoma (GBM) remains dismal despite maximal surgical resection followed by aggressive chemo-radiation therapy. Almost every GBM, regardless of genotype, relapses as aggressive recurrent disease. Sensitization of GBM c
Externí odkaz:
https://doaj.org/article/aadda5d7499241cebbf1b673ba724aab
Autor:
Gaspar J. Kitange, Ann C. Mladek, Mark A. Schroeder, Jenny C. Pokorny, Brett L. Carlson, Yuji Zhang, Asha A. Nair, Jeong-Heon Lee, Huihuang Yan, Paul A. Decker, Zhiguo Zhang, Jann N. Sarkaria
Publikováno v:
Cell Reports, Vol 14, Iss 11, Pp 2587-2598 (2016)
Here we provide evidence that RBBP4 modulates temozolomide (TMZ) sensitivity through coordinate regulation of two key DNA repair genes critical for recovery from TMZ-induced DNA damage: methylguanine-DNA-methyltransferase (MGMT) and RAD51. Disruption
Externí odkaz:
https://doaj.org/article/8e14b685c3304c7fa147e80847088793
Autor:
Ravi D. Rao, Ann C. Mladek, Jeffrey D. Lamont, Jennie M. Goble, Charles Erlichman, C. David James, Jann N. Sarkaria
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 7, Iss 10, Pp 921-929 (2005)
Elevated epidermal growth factor receptor (EGFR) and mammalian target of rapamycin (mTOR) signaling are known to contribute to the malignant properties of glioblastoma multiforme (GBM), which include uncontrolled cell proliferation and evasion of apo
Externí odkaz:
https://doaj.org/article/1115f966e5754d1c80e56b364df5c242
Autor:
Jason E Conage-Pough, Sylwia A Stopka, Ju-Hee Oh, Ann C Mladek, Danielle M Burgenske, Michael S Regan, Gerard Baquer, Paul A Decker, Brett L Carlson, Katrina K Bakken, Jinqiang Zhang, Lily Liu, Claire Sun, Zhihua Mu, Wei Zhong, Nhan L Tran, William F Elmquist, Nathalie Y R Agar, Jann N Sarkaria, Forest M White
Publikováno v:
Neuro-Oncology Advances.
Background Although the epidermal growth factor receptor (EGFR) is a frequent oncogenic driver in glioblastoma (GBM), efforts to therapeutically target this protein have been largely unsuccessful. The present pre-clinical study evaluated the novel EG
Autor:
Jann N. Sakaria, Richard T. Wheelhouse, Alonzo H. Ross, Jarkko Rautio, Mikko Gynther, Roger M. Phillips, Ann C. Mladek, Yulian P. Ramirez
Supplementary Figure S5. DNA damage signaling activated by low concentrations of DP68. U251 and T98G cells were exposed to DP68 for 24 hrs and whole cell and nuclear extracts were processed for Western blotting. Representative blots from three indepe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0434cb986f1d6fcbe341f24a6769684
https://doi.org/10.1158/1535-7163.22502478.v1
https://doi.org/10.1158/1535-7163.22502478.v1
Autor:
Jann N. Sakaria, Richard T. Wheelhouse, Alonzo H. Ross, Jarkko Rautio, Mikko Gynther, Roger M. Phillips, Ann C. Mladek, Yulian P. Ramirez
Legends for Supplementary Figures S1-S5.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2008589948c047711f1a08855ba858c4
https://doi.org/10.1158/1535-7163.22502496
https://doi.org/10.1158/1535-7163.22502496
Autor:
Jann N. Sarkaria, William F. Elmquist, Andrew A. Protter, Ying Feng, Yuqiao Shen, Gaspar J. Kitange, Paul A. Decker, Mark A. Schroeder, Ann C. Mladek, Katrina K. Bakken, Brett L. Carlson, Karen E. Parrish, Ryo Kawashima, Kenneth Chang, Shiv K. Gupta, Sani H. Kizilbash
Evaluation of sensitizing effects of TAL in GBM cell lines
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37be1fdfda968d46ee4b4d22cb01bc32
https://doi.org/10.1158/1535-7163.22505305.v1
https://doi.org/10.1158/1535-7163.22505305.v1
Autor:
Jann N. Sarkaria, William F. Elmquist, Andrew A. Protter, Ying Feng, Yuqiao Shen, Gaspar J. Kitange, Paul A. Decker, Mark A. Schroeder, Ann C. Mladek, Katrina K. Bakken, Brett L. Carlson, Karen E. Parrish, Ryo Kawashima, Kenneth Chang, Shiv K. Gupta, Sani H. Kizilbash
Supplementary methods and Captions to the Supplementary Figures
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c1dd961369700b863b7c74aa06bee26
https://doi.org/10.1158/1535-7163.22505281.v1
https://doi.org/10.1158/1535-7163.22505281.v1
Autor:
Jann N. Sarkaria, William F. Elmquist, Paul A. Decker, Mark A. Schroeder, Ann C. Mladek, Katrina K. Bakken, Brett L. Carlson, Gautham Gampa, Minjee Kim, Janice K. Laramy, Karen E. Parrish, Shiv K. Gupta, Sani H. Kizilbash
Tesevatinib is a potent oral brain penetrant EGFR inhibitor currently being evaluated for glioblastoma therapy. Tesevatinib distribution was assessed in wild-type (WT) and Mdr1a/b(-/-)Bcrp(-/-) triple knockout (TKO) FVB mice after dosing orally or vi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::206b43b8da91279e8c66cb03985a2c44
https://doi.org/10.1158/1535-7163.c.6543372
https://doi.org/10.1158/1535-7163.c.6543372